COVID-19 apparently causes, at least in part, imbalances in the RAS by negativelyregulating ACE2, thereby exacerbating the ACE/AngII/AT1R axi53, and producing predominantly proinflammatory effects. Here, AGTR1 is linked to COVID-19.